NEW YORK and LEAMINGTON, Ontario - Tilray Brands Inc. (NASDAQ:TLRY; TSX:TLRY) announced Wednesday the acquisition of Lyphe Group, a UK-based medical cannabis clinic and digital pharmacy platform, according to a press release statement.
Lyphe Dispensary has dispensed approximately 150,000 units to date, while Lyphe Clinic has treated over 16,000 patients. The acquisition establishes Tilray Medical’s first vertically integrated patient-centric medical platform in the UK, combining...